Northwestern Mutual Wealth Management Co. trimmed its position in shares of Davita Inc (NYSE:DVA) by 27.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,368 shares of the company’s stock after selling 905 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Davita were worth $171,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. Oak Associates Ltd. OH lifted its holdings in shares of Davita by 21.1% during the 2nd quarter. Oak Associates Ltd. OH now owns 185,195 shares of the company’s stock valued at $11,993,000 after buying an additional 32,285 shares during the period. Eqis Capital Management Inc. lifted its holdings in shares of Davita by 62.5% during the 3rd quarter. Eqis Capital Management Inc. now owns 7,473 shares of the company’s stock valued at $444,000 after buying an additional 2,873 shares during the period. Xact Kapitalforvaltning AB lifted its holdings in shares of Davita by 22.8% during the 3rd quarter. Xact Kapitalforvaltning AB now owns 19,851 shares of the company’s stock valued at $1,179,000 after buying an additional 3,685 shares during the period. Founders Capital Management LLC lifted its holdings in shares of Davita by 2.3% during the 3rd quarter. Founders Capital Management LLC now owns 95,939 shares of the company’s stock valued at $5,698,000 after buying an additional 2,115 shares during the period. Finally, Speece Thorson Capital Group Inc. lifted its holdings in shares of Davita by 14.5% during the 3rd quarter. Speece Thorson Capital Group Inc. now owns 321,182 shares of the company’s stock valued at $19,075,000 after buying an additional 40,667 shares during the period. 86.71% of the stock is currently owned by hedge funds and other institutional investors.

In other news, insider James K. Hilger sold 5,608 shares of the company’s stock in a transaction on Thursday, December 7th. The stock was sold at an average price of $69.46, for a total value of $389,531.68. Following the completion of the sale, the insider now directly owns 47,649 shares in the company, valued at approximately $3,309,699.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Kent J. Thiry sold 81,800 shares of the company’s stock in a transaction on Friday, December 8th. The stock was sold at an average price of $68.04, for a total value of $5,565,672.00. The disclosure for this sale can be found here. Insiders sold a total of 121,509 shares of company stock valued at $8,310,388 over the last 90 days. 2.10% of the stock is currently owned by company insiders.

Shares of Davita Inc (DVA) opened at $71.91 on Friday. The company has a quick ratio of 1.35, a current ratio of 1.40 and a debt-to-equity ratio of 1.79. The company has a market capitalization of $13,685.18, a price-to-earnings ratio of 27.66 and a beta of 0.99. Davita Inc has a 12 month low of $52.51 and a 12 month high of $80.71.

Several equities analysts have recently weighed in on DVA shares. Wolfe Research raised Davita from a “market perform” rating to an “outperform” rating in a report on Monday, October 23rd. Bank of America lowered their price target on Davita from $75.00 to $66.00 and set a “neutral” rating on the stock in a report on Wednesday, November 8th. Raymond James Financial raised Davita from an “outperform” rating to a “strong-buy” rating and increased their price target for the company from $65.00 to $84.00 in a report on Thursday, December 7th. Royal Bank of Canada reduced their price objective on Davita from $64.00 to $60.00 and set a “sector perform” rating for the company in a research note on Wednesday, November 8th. Finally, JPMorgan Chase & Co. upped their price objective on Davita from $4.90 to $84.00 and gave the stock a “strong-buy” rating in a research note on Thursday, December 7th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating, five have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $78.60.

COPYRIGHT VIOLATION NOTICE: “Davita Inc (DVA) Shares Sold by Northwestern Mutual Wealth Management Co.” was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.dailypolitical.com/2018/02/09/davita-inc-dva-shares-sold-by-northwestern-mutual-wealth-management-co.html.

Davita Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.